Subscribe To
Taro pharmaceutical: stagnating growth at 1.6% trailing earnings yield, rate hold
Taro pharmaceutical's quarterly numbers came in with very thin growth at the operating and bottom-lines...
February 24, 2023, 12:18 am
Editas: the potential of gene editing technology and the risks of a lackluster pipeline
If EDIT-101 continues to show positive results, it has the potential to become the first-ever gene-editing therapy approved for a genetic disease. Edi...
February 23, 2023, 10:39 pm
Collegium pharmaceutical, inc. (coll) q4 2022 earnings call transcript
Collegium pharmaceutical, Inc. (NASDAQ:COLL ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 P...
February 23, 2023, 10:07 pm
Collegium pharmaceutical (coll) q4 earnings and revenues beat estimates
Collegium pharmaceutical (COLL) delivered earnings and revenue surprises of 5.83% and 2%, respectively,...
February 23, 2023, 6:49 pm
Longboard pharmaceuticals to report full year 2022 financial results and key corporate initiatives on march 2, 2023
SAN DIEGO--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard pharmaceuticals, Inc. (Nasdaq: LBPH), a clini...
February 23, 2023, 4:31 pm
Arrowhead pharmaceuticals requires caution
Arrowhead pharmaceuticals, Inc. is a company with strong potential. However, it has yet to conclusively...
February 23, 2023, 2:19 pm
Alnylam pharmaceuticals, inc. (alny) q4 2022 earnings call transcript
Alnylam pharmaceuticals, Inc. (NASDAQ:ALNY ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM...
February 23, 2023, 1:46 pm
Biotech m&a could finally be ready to rebound
One of the long-running catalysts for small- and mid-sized biotechnology companies is the possibility that they'll eventually be acquired by large-cap...
February 23, 2023, 12:05 pm
Agios pharmaceuticals, inc. (agio) q4 2022 earnings call transcript
Agios pharmaceuticals, Inc. (NASDAQ:AGIO ) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM E...
February 23, 2023, 11:35 am
Ligand's (lgnd) q4 sales & earnings top, view raised, stock up
Ligand pharmaceuticals (LGND) announces better-than-expected results in fourth-quarter 2022. Stock is u...
February 23, 2023, 9:02 am
Provention bio to report fourth quarter and full year 2022 financial results on march 16, 2023
RED BANK, N.J. , Feb. 23, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharm...
February 23, 2023, 8:30 am
Cti biopharma to report fourth quarter and full year 2022 financial results and provide corporate update on monday, march 6, 2023
SEATTLE , Feb. 23, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical...
February 23, 2023, 7:03 am
Astrazeneca signs deal to produce new gastric cancer drug
AstraZeneca PLC (LSE:AZN), Britain's largest pharmaceutical company, has agreed a licensing deal with K...
February 23, 2023, 6:29 am
Medivir to present at the erik penser bank healthcare day
STOCKHOLM , Feb. 23, 2023 /PRNewswire/ -- Medivir AB (Stockholm: MVIR), a pharmaceutical company focus...
February 23, 2023, 3:03 am
Ligand pharmaceuticals (lgnd) surpasses q4 earnings and revenue estimates
Ligand (LGND) delivered earnings and revenue surprises of 10.57% and 24.42%, respectively, for the quarter ended December 2022. Do the numbers hold cl...
February 22, 2023, 9:49 pm
Ligand pharmaceuticals, inc. (lgnd) q4 2022 earnings call transcript
Ligand pharmaceuticals, Inc. (NASDAQ:LGND ) Q4 2022 Earnings Conference Call February 22, 2023 4:00 PM ...
February 22, 2023, 9:41 pm
Lightning round: stay long berkshire hathaway
Mad Money host Jim Cramer takes questions on specific stocks, including Berkshire Hathaway, VF Corp., Tesla, Teva ...
February 22, 2023, 7:41 pm
Kala pharmaceuticals (kala) flat as market sinks: what you should know
Kala pharmaceuticals (KALA) closed the most recent trading day at $11.90, making no change from the pre...
February 22, 2023, 7:34 pm
Moderna stock pops after receiving cancer-vaccine candidate gets fda breakthrough designation
Moderna Inc. MRNA, -1.20% and Merck Inc. MRK, +0.08% shares increased in after-hours trading Wednesday after the ...
February 22, 2023, 4:21 pm
Why shares of biocryst pharmaceuticals jumped today
A day after the stock plummeted, it bounced back....
February 22, 2023, 3:29 pm